Table 1.
Total Anti-HCV(+) Patients | 18-35 | 35-45 | 45-55 | 55-65 | >65 | |
---|---|---|---|---|---|---|
Before COVID-19 | 674 | 74 (11%) | 86 (12.7%) | 101 (15) | 177 (26.3%) | 236 (35%) |
During COVID-19 | 480 | 69 (14.4%) | 68 (14.3%) | 87 (18.1%) | 126 (26.2%) | 130 (27%) |
P | .084 | .302 | .154 | .997 | .004 |
HCV, hepatitis C virus.
P <.05 is the signifant cut off point.